Corrigendum: Interferon-α2b Treatment for COVID-19 (Frontiers in Immunology, (2020), 11, (1061), 10.3389/fimmu.2020.01061)

Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao Shan Wei, Xuan Xiang, Xu Wang, Zi Hao Wang, Scott J. Tebbutt, Tobias R. Kollmann, Eleanor N. Fish

Research output: Contribution to journalComment/debate

Abstract

In the original article, there was a mistake in Table 1 as published. For ‘Days from symptom onset to treatment,’ the IFN+ARB and ARB values were inadvertently switched. IFN+ARB should be 8.0 [5.0,11.0] and ARB should be 17.0 [10.0, 22.0]. The corrected Table 1 appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number615275
JournalFrontiers in Immunology
Volume11
DOIs
Publication statusPublished - 27 Oct 2020

Fingerprint Dive into the research topics of 'Corrigendum: Interferon-α2b Treatment for COVID-19 (Frontiers in Immunology, (2020), 11, (1061), 10.3389/fimmu.2020.01061)'. Together they form a unique fingerprint.

Cite this